Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Foreign Currency Transaction Gain (Loss), Unrealized

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), Unrealized

Tempest Therapeutics, Inc. (TPST) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$98.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2019-11-13

  • Tempest Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2018-09-30 was -$37.00K.
  • Tempest Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2018-06-30 was -$64.00K.
  • Tempest Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2018-03-31 was $3.00K.
Period endForeign Currency Transaction Gain (Loss), Unrealized 3 monthForeign Currency Transaction Gain (Loss), Unrealized 6 monthForeign Currency Transaction Gain (Loss), Unrealized 9 month
2018-09-30-$37.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
-$101.00K
derived: sum of 2 quarters · filed 2019-11-13
-$98.00K
10-Q · filed 2019-11-13
2018-06-30-$64.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
-$61.00K
10-Q · filed 2019-08-12
2018-03-31$3.00K
10-Q · filed 2019-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B